Linkage Biosciences Inks European Distribution Deal With Voden | GenomeWeb

NEW YORK (GenomeWeb) – Linkage Biosciences today announced a distribution partnership with Voden Medical Instruments.

The deal gives Voden rights to distribute Linkage's genetic testing, including the real-time PCR-based LinkSeq human leukocyte antigen (HLA) test.

"Voden Medical possesses a long standing record of excellent customer service and proven technical expertise, particularly in the area of HLA testing," Linkage Biosciences CEO Zachary Antovich said in a statement.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.